6 employees
Lmito Therapeutics is a clinical-stage company that develops innovative therapy through the modulation of cell metabolism.
2017
Lmito Therapeutics raised undisclosed on August 26, 2020
Investors: Yuanta Investment Korea (유안타인베스트먼트), Kiwoom Investment and Stonebridge Ventures